CVE-2022-29152
The Ericom PowerTerm WebConnect 6.0 login portal can unsafely write an XSS payload from the...
The Ericom PowerTerm WebConnect 6.0 login portal can unsafely write an XSS payload from the AppPortal cookie into the page.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- Required
What an attacker can affect
- Confidentiality
- Low
- Integrity
- Low
- Availability
- None
Exploit likelihood
What each source reports
NVD Score used
The Ericom PowerTerm WebConnect 6.0 login portal can unsafely write an XSS payload from the AppPortal cookie into the page.
- Record
CVE-2022-29152- CVSS 3.1
- 6.1 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N - CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:N/I:P/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
CVE List No score
The Ericom PowerTerm WebConnect 6.0 login portal can unsafely write an XSS payload from the AppPortal cookie into the page.
- Record
CVE-2022-29152- Updated
- 2026-11-02
EUVDEUVD-2022-33561 No score
The Ericom PowerTerm WebConnect 6.0 login portal can unsafely write an XSS payload from the AppPortal cookie into the page.
- Record
EUVD-2022-33561- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-f388-xh2q-wcwr
The Ericom PowerTerm WebConnect 6.0 login portal can unsafely write an XSS payload from the...
The Ericom PowerTerm WebConnect 6.0 login portal can unsafely write an XSS payload from the AppPortal cookie into the page.
- Record
GHSA-f388-xh2q-wcwr- CVSS 3.1
- 6.1 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2022-29152 is a medium vulnerability (CVSS 6.1) in Ericom Powerterm Webconnect, published April 28, 2022. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.57%, the 47th percentile. No source names a fixed version.